Malaria and erythrocyte glucose-6-phosphate dehydrogenase variants in West Africa

Area of Science:

• Medical research
• Genetics
• Infectious diseases

Background:

• Malaria remains a significant public health challenge, particularly in malaria-endemic regions like Nigeria.
• Glucose-6-phosphate dehydrogenase (G6PD) deficiency is a common genetic disorder that affects red blood cells.
• The relationship between G6PD deficiency and malaria susceptibility is complex and varies by genetic status.

Purpose of the Study:

• To investigate the impact of glucose-6-phosphate dehydrogenase (G6PD) status on malaria morbidity and parasitemia in Nigerian children.
• To determine if specific G6PD genotypes confer a protective advantage against malaria infection.

Main Methods:

• A clinical study involving 702 Nigerian children aged 1-6 years.
• Assessment of malaria parasitemia and clinical morbidity.
• Comparison of outcomes based on glucose-6-phosphate dehydrogenase (G6PD) enzyme status.

Main Results:

• Analysis revealed differences in malaria morbidity and parasitemia rates among children with varying G6PD statuses.
• Heterozygous females carrying the G6PD deficiency gene (GdA-/GdB) demonstrated a significant advantage against malaria.
• This suggests a protective effect conferred by the heterozygous G6PD deficient genotype.

Conclusions:

• The G6PD deficient genotype (GdA-/GdB) in heterozygous females provides a survival advantage against malaria in the studied population.
• These findings contribute to understanding the complex interplay between genetic factors and infectious disease resistance.
• Further research into G6PD deficiency and malaria interactions is warranted for public health strategies.